{"schema_version":"secwatch.filing_event.v1","accession":"0001477932-23-002272","form_type":"8-K","ticker":"BICX","cik":"0001443863","company_name":"BioCorRx Inc.","filed_at":"2023-04-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:38.890907+00:00","generated_at":"2026-06-17T05:48:37.505366+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"BioCorRx raises $600k from directors via stock and warrants; converts $314k note to equity","bullets":["Directors Galligan and Lucido each invest $300k at $1.75/share, receive warrants for equal shares at $4.00.","Lucido exchanges $313,892 promissory note for 183,606 shares of common stock, canceling the note.","Total shares issued: 342,592 from subscriptions plus 183,606 from note exchange = 526,198 shares.","Warrants exercisable for 3 years at $4.00 per share, issued to both directors.","Securities issued in private placement exempt from registration under Section 4(a)(2)."],"urls":{"canonical":"https://secwatch.observer/filing/0001477932-23-002272","json":"https://secwatch.observer/filing/0001477932-23-002272.json","markdown":"https://secwatch.observer/filing/0001477932-23-002272.md","text":"https://secwatch.observer/filing/0001477932-23-002272.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002272/0001477932-23-002272-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1443863/000147793223002272/bicx_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T05:48:37.505366+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}